Skip to main content

and
  1. Article

    Open Access

    Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial

    Immunotherapy combined with chemotherapy has been demonstrated to be effective in early triple-negative breast cancer (TNBC). In this single-arm, phase II study with Simon’s two-stage design, we investigated t...

    Chengzheng Wang, Zhenzhen Liu, **uchun Chen, Jianghua Qiao in Nature Communications (2023)